Clostridioides difficile infection

Probiotic research

14 PubMed publications related to this topic.

• Add-on interventions for the prevention of recurrent Clostridioides Difficile infection: A systematic review and network meta-analysis.
  Anaerobe
  Evidence: High
• Evaluation of probiotics efficiency for the prevention of Clostridioides difficile infection in hospitalized patients: a systematic review and meta-analysis.
  Infection
  Evidence: High
• Efficacy and safety of Saccharomyces boulardii as adjunct therapy with Vancomycin in treating Clostridioides difficile infection: A randomized controlled trial.
  Scientific reports
  Evidence: High
• Do probiotics prevent antibiotic-associated diarrhoea? Results of a multicentre randomized placebo-controlled trial.
  The Journal of hospital infection
  Evidence: High
• Diarrhea in Mechanically Ventilated Patients: A Nested Multicenter Substudy.
  Critical care medicine
  Evidence: High
• Effect of Probiotics on Incident Ventilator-Associated Pneumonia in Critically Ill Patients: A Randomized Clinical Trial.
  JAMA
  Evidence: High
• Implementation strategies for hospital-based probiotic administration in a stepped-wedge cluster randomized trial design for preventing hospital-acquired Clostridioides difficile infection.
  BMC health services research
  Evidence: High
• Microbiome and Metabolome Restoration After Administration of Fecal Microbiota, Live-jslm (REBYOTA) for Preventing Recurrent Clostridioides difficile Infection.
  The Journal of infectious diseases
  Evidence: High
• VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial.
  JAMA
  Evidence: High
• When It's Too Trying for Trials: A Commentary on a Different Approach for Testing a Probiotic, Saccharomyces boulardii, to Prevent Healthcare-associated Clostridioides difficile Infections.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  Evidence: Low
• Clostridioides difficile Infections: Prevention and Treatment Strategies.
  Advances in experimental medicine and biology
  Evidence: Low
• Metabolic modeling reveals determinants of prebiotic and probiotic treatment efficacy across multiple human intervention trials.
  PLoS biology
  Evidence: Low
• The Acid-Dependent and Independent Effects of Lactobacillus acidophilus CL1285, Lacticaseibacillus casei LBC80R, and Lacticaseibacillus rhamnosus CLR2 on Clostridioides difficile R20291.
  Probiotics and antimicrobial proteins
  Evidence: Low
• Perils and pitfalls of probiotic quasi-experimental studies for primary prevention of Clostridioides difficile infection: A review of the evidence.
  American journal of infection control
  Evidence: Low